Trends in melanoma in the elderly in Denmark, 1980-2012

Acta Oncologica
Lise HoejbergAcademy of Geriatric Cancer Research (AgeCare)

Abstract

The incidence of melanoma is rising in Denmark. In the present paper we describe incidence, mortality and survival in Denmark from 1980 to 2012 focusing on age, comparing persons aged 70 years or more with those aged less than 70 years. Melanoma was defined as ICD-10 code C43. Data derived from the NORDCAN database with comparable data on incidence, mortality, survival in the Nordic countries, where the Danish data were delivered from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up until the end of 2013. In 1980, 21.4% of the patients diagnosed with melanoma were older than 70 years compared to 28.4% in 2012. In persons aged less than 70 years, the incidence rate was higher among women than in men, but men aged 70-89 years had an incidence rate almost twice that of women. Incidence rates were increasing, particularly among the elderly. In 1980, 32.6% of the patients who died from melanoma were older than 69 years compared to 56.2% in 2012. In 1980, the mortality rate was 121.4 per 100,000 person years, increasing to 353.1 in 2012. For the younger patients, the mortality rates are only slight increasing, but for the elder patients the mortality rates are increasing dramatically. In general the su...Continue Reading

References

Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Sep 26, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C CaracòN Mozzillo
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marit Bragelien VeierødElisabete Weiderpass
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georgina V LongRichard F Kefford
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Sep 1, 2011·Annals of Surgical Oncology·Julie R LangeCharles M Balch
Nov 16, 2011·Journal of Cancer·James B MacdonaldBarbara A Pockaj
Feb 27, 2013·Scandinavian Journal of Public Health·Johan MoanAsta Juzeniene
Jul 11, 2013·Annals of Surgical Oncology·Charles M BalchVernon K Sondak
Oct 10, 2013·Anti-cancer Agents in Medicinal Chemistry·Giulia MalaguarneraRosario Emanuele Perrotta
Jul 22, 2014·Melanoma Research·Alfonso BerrocalUNKNOWN Spanish Melanoma Group
Jan 20, 2016·Acta Oncologica·Marianne EwertzUNKNOWN Academy of Geriatric Cancer Research (AgeCare)

❮ Previous
Next ❯

Citations

Jan 27, 2017·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·UNKNOWN United Nations Environment Programme, Environmental Effects Assessment Panel
Jul 28, 2019·Acta Oncologica·Melinda S SchuurmanMarieke W J Louwman
Nov 28, 2018·Melanoma Research·Fortunato BianconiFabrizio Stracci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Oncologica
Jeanette D JensenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Nessn H AzawiAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Charlotte KristiansenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
M EwertzAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Rikke H DahlrotAcademy of Geriatric Cancer Research (AgeCare)
© 2022 Meta ULC. All rights reserved